OTCMKTS:TRUMY - TERUMO CORP/ADR Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $55.69 0.00 (0.00 %) (As of 01/18/2019 04:00 PM ET)Previous Close$55.69Today's Range$55.69 - $55.6952-Week Range$47.74 - $62.05Volume59 shsAverage Volume326 shsMarket Capitalization$21.15 billionP/E Ratio24.32Dividend Yield0.73%Beta0.4 ProfileDiscussionChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Terumo Corporation develops, manufactures, and distributes medical devices and services worldwide. It provides products for use in cardiothoracic surgery, interventional procedure, and medicine transfusion. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro balloon catheters, micro catheters and guide wires, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenators with integrated arterial filters, heart-lung machines, and devices for operating a centrifugal pumps for extracorporeal life support systems; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems; closed anticancer drug infusion systems; blood glucose monitoring systems, digital blood pressure monitors, digital thermometers, pulse oximeters, walking intensity monitors, body composition monitors, and HR joint meter/monitors; sprayable adhesion barrier gels; analgesics; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices and fluids. Further, it provides other consumer healthcare products, such as basal thermometers, fall prevention products, oral care products, and urine test strips; and blood bag systems with leukocyte reduction filters, automated blood collection and blood component processing systems, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan. Receive TRUMY News and Ratings via Email Sign-up to receive the latest news and ratings for TRUMY and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Medical & hospital equipment Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:TRUMY Previous SymbolNASDAQ:TRUMY CUSIPN/A Webwww.terumo.com Phone813-3374-8111Debt Debt-to-Equity Ratio0.46 Current Ratio2.51 Quick Ratio1.77Price-To-Earnings Trailing P/E Ratio24.32 Forward P/E Ratio27.03 P/E Growth3.86 Sales & Book Value Annual Sales$5.31 billion Price / Sales3.98 Cash Flow$3.1678 per share Price / Cash Flow17.58 Book Value$13.05 per share Price / Book4.27Profitability EPS (Most Recent Fiscal Year)$2.19 Net Income$821.65 million Net Margins15.78% Return on Equity16.44% Return on Assets8.60%Miscellaneous EmployeesN/A Outstanding Shares379,760,000Market Cap$21.15 billion OptionableNot Optionable TERUMO CORP/ADR (OTCMKTS:TRUMY) Frequently Asked Questions What is TERUMO CORP/ADR's stock symbol? TERUMO CORP/ADR trades on the OTCMKTS under the ticker symbol "TRUMY." How were TERUMO CORP/ADR's earnings last quarter? TERUMO CORP/ADR (OTCMKTS:TRUMY) announced its quarterly earnings data on Thursday, November, 8th. The company reported $0.40 earnings per share (EPS) for the quarter. The business had revenue of $1.27 billion for the quarter. TERUMO CORP/ADR had a return on equity of 16.44% and a net margin of 15.78%. View TERUMO CORP/ADR's Earnings History. When is TERUMO CORP/ADR's next earnings date? TERUMO CORP/ADR is scheduled to release their next quarterly earnings announcement on Thursday, February 14th 2019. View Earnings Estimates for TERUMO CORP/ADR. Has TERUMO CORP/ADR been receiving favorable news coverage? Media stories about TRUMY stock have been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm rates the sentiment of news coverage by reviewing more than six thousand news and blog sources. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores closest to five being the most favorable. TERUMO CORP/ADR earned a media sentiment score of 1.7 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 1.0 out of 10, indicating that recent news coverage is extremely unlikely to have an effect on the stock's share price in the next several days. Who are some of TERUMO CORP/ADR's key competitors? Some companies that are related to TERUMO CORP/ADR include Bristol-Myers Squibb (BMY), Aetna (AET), Biogen (BIIB), Anthem (ANTM), Becton Dickinson and (BDX), Stryker (SYK), Intuitive Surgical (ISRG), Bayer (BAYRY), Celgene (CELG), Shire (SHPG), Allergan (AGN), Express Scripts (ESRX), Boston Scientific (BSX), Vertex Pharmaceuticals (VRTX) and HCA Healthcare (HCA). Who are TERUMO CORP/ADR's key executives? TERUMO CORP/ADR's management team includes the folowing people: Mr. David B. Perez, Sr. Exec. Officer & Director (Age 60)Mr. Shinjiro Sato, Pres, CEO & DirectorRyo Nishihata, Sr. Exec. Officer and Chief Accounting & Financial OfficerMr. Hiroaki Kasukawa, CTO & Exec. OfficerKatsuya Takeuchi, Chief Information Officer & Exec. Officer How do I buy shares of TERUMO CORP/ADR? Shares of TRUMY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is TERUMO CORP/ADR's stock price today? One share of TRUMY stock can currently be purchased for approximately $55.69. How big of a company is TERUMO CORP/ADR? TERUMO CORP/ADR has a market capitalization of $21.15 billion and generates $5.31 billion in revenue each year. The company earns $821.65 million in net income (profit) each year or $2.19 on an earnings per share basis. What is TERUMO CORP/ADR's official website? The official website for TERUMO CORP/ADR is http://www.terumo.com. How can I contact TERUMO CORP/ADR? TERUMO CORP/ADR's mailing address is 2-44-1 Hatagaya Shibuya-ku, Tokyo M0, 151-0072. The company can be reached via phone at 813-3374-8111 or via email at [email protected] MarketBeat Community Rating for TERUMO CORP/ADR (OTCMKTS TRUMY)Community Ranking: 2.5 out of 5 ( )Outperform Votes: 50 (Vote Outperform)Underperform Votes: 52 (Vote Underperform)Total Votes: 102MarketBeat's community ratings are surveys of what our community members think about TERUMO CORP/ADR and other stocks. Vote "Outperform" if you believe TRUMY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TRUMY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 1/19/2019 by MarketBeat.com StaffFeatured Article: What is Depreciation?